ArticleJournal of animal science2026
Bacillus cell‑free supernatants support canine epithelial barrier function and stress adaptation through anti-inflammatory and anti-apoptotic mechanisms.
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Barrier and Immune Modulation byInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disruption of epithelial barrier function and inflammation compromise canine health and wellbeing, particularly in the gastrointestinal tract. Bacillus spp. produce bioactive components, here investigated as cell‑free supernatant (CFS), that can modulate epithelial barrier‑associated pathways. We evaluated the effects of CFS from 3 probiotic Bacillus strains on biomarkers of barrier integrity, the immune response and survival of canine proximal epithelial (MCA-B1) cells, and on the phagocytic activity of canine DH82 macrophages. CFS from Bacillus licheniformis strains BA842 and BL-21 and Bacillus velezensis strain 27 (equivalent to 1 × 107 colony-forming units [CFU]/mL per well) was applied to cells and incubated overnight. Tight junction (TJ) expression and adhesion protein molecule abundance were assessed by RT-qPCR and proteomics, respectively; cytokines and apoptosis markers were analyzed under LPS-stimulated and unstimulated conditions; metabolite abundance in CFS following incubation with MCA-B1 cells was assessed using metabolomic profiling, and phagocytic activity was determined using a fluorescein-labeled Escherichia coli uptake assay. The CFS from BA842 and BL-21 increased the expression of CLDN1 (by 2.4 ± 0.2-fold and 2.5 ± 0.2-fold, respectively, vs. control; P < 0.001), and CLDN4 (by 1.9 ± 0.2-fold and 2.3 ± 0.2-fold, respectively; P < 0.01); BA842 CFS also increased ZO-1 and E-cadherin expression (P < 0.01). The cytokine expression profile of CFS-treated cells shifted towards a more balanced phenotype; BA842- and BL-21-CFS increased IL-8 expression (6.9 and 8.5-fold vs. control, respectively; P < 0.001), and BL-21 also increased IL-12A expression (1.6-fold vs. control, respectively; P < 0.01). In addition, BA842-CFS increased BCL2 expression and BCL2L1 abundance (1.5-fold and 2.0-fold vs. control; P < 0.05) and BL-21- and 27-CFS reduced caspase-8 expression (P < 0.05). Macrophage phagocytosis increased after exposure to BA842 CFS (+194% vs. control; P < 0.01). Untargeted metabolomics identified increased Lac-Phe after 24 h in CFS-treated MCA-B1 cultures but not in tryptic soy agar, suggesting that this metabolite is associated with epithelial cell interaction rather than being a component of the growth medium. In conclusion, Bacillus-derived CFS modulated expression of TJ proteins, adhesion molecules, cytokines, and markers of apoptosis in canine epithelial cells and enhanced macrophage phagocytic activity, linked to defined metabolomic responses, providing mechanistic insight to support epithelial barrier‑relevant functions associated with canine health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.